Department of the Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland.
Department of Basic Nursing, Medical University of Warsaw.
Otolaryngol Pol. 2023 Dec 4;77(6):43-50. doi: 10.5604/01.3001.0054.0941.
A novel strategy for the treatment of allergic rhinitis results from the innovative combination of antihistamine and intranasal corticosteroid drugs. By combining two preparations with different mechanism of action, this novel approach facilitates quick and effective controls of all upper respiratory tract allergy symptoms. The article presents the results of a study of olopatadine hydrochloride and mometasone furoate fixed-dose combination (GSP301) administered intranasally from a spray formulation, with an attempt at positioning the treatment within the ARIA and EPOS guidelines.
一种治疗过敏性鼻炎的新策略源于抗组胺药和鼻内皮质类固醇药物的创新联合。通过将两种具有不同作用机制的制剂联合使用，这种新方法可以快速有效地控制所有上呼吸道过敏症状。本文介绍了盐酸奥洛他定和糠酸莫米松固定剂量组合（GSP301）经鼻喷雾剂给药的研究结果，尝试将该治疗方法定位在 ARIA 和 EPOS 指南内。
